Ligand validation:8FJV

GAR: GLYCINAMIDE RIBONUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FJV_GAR_A_1101	52%	37%	0.19	0.947	0.87	1.58	1	4	1	0	100%	1
4ZZ1_GAR_A_1101	99%	59%	0.051	0.989	0.51	1.03	-	1	0	0	100%	1
4ZYW_GAR_A_1101	95%	59%	0.073	0.979	0.59	0.96	-	1	0	0	100%	1
5J9F_GAR_A_1101	94%	40%	0.083	0.984	0.81	1.49	1	2	0	0	100%	1
4ZYZ_GAR_A_1101	94%	58%	0.071	0.969	0.51	1.07	-	1	0	0	100%	0.82
4ZYT_GAR_A_1101	93%	58%	0.078	0.972	0.52	1.09	-	1	1	0	100%	0.85
1KJ8_GAR_B_398	100%	56%	0.046	0.987	0.76	0.95	1	1	0	0	100%	1
1EZ1_GAR_B_411	99%	50%	0.051	0.983	0.78	1.15	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.